NEW YORK (GenomeWeb) – CompanionDx Reference Lab and Rx Review Service are partnering in an effort to increase the use of pharmacogenomics testing under a deal announced today.

Specifically, the firms seek to increase the availability of qualified pharmacogenomic testing to healthcare institutions and doctor practices in order to improve patient therapy. "The partnership provides an opportunity to grow and expand market presence, bringing the benefits of pharmacogenomic testing to the entire healthcare industry," Rx Review Service President Jerry Wanio said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.